Find clinical trials for Non-Small-Cell Lung Cancer in Dallas, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Dallas, TX, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Dallas, Texas, United States and 83 other locations
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Fort Worth, Texas, United States and 47 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Dallas, Texas, United States and 59 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Fort Worth, Texas, United States and 209 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Dallas, Texas, United States and 126 other locations
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...
Phase 2, Phase 3
Plano, Texas, United States and 48 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Fort Worth, Texas, United States and 230 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Fort Worth, Texas, United States and 282 other locations
This is a phase 1, multicenter, open-label, first-in-human study of YL202 conducted in the United States and China.The study will evaluate the safety...
Phase 1
Irving, Texas, United States and 12 other locations
A Phase 2 study evaluating STRO-002 in subjects with previously treated advanced or metastatic non-small cell lung...
Phase 2
Dallas, Texas, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal